In chronic myeloid leukemia (CML), TOPK is regulated by BCR/ABL, and its inhibition with OTS514 suppresses cell proliferation and colony formation, underscoring its therapeutic relevance 127. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.